ESTUTC-5 New YorkLog in Sign up

ALPMY
ASTELLAS PHARMA UNSP/ADR
stockOTCADR

EODNov 13, 2026

16.85USD+2.029%(+0.34)274,487

Loading…

Loading…

29.88B

Healthcare

Drug Manufacturers-General

HQ

Tokyo, Tokyo To, Japan

14,484

Previous Close

$16.48

Beta

0.46

52-Week High

$17.35 2026-03-30

52-Week Low

$11.96 2025-11-13

SMA 50

$15.22

SMA 200

$14.80

Avg. Vol 10D

117,310

Avg. Vol 30D

107,356

Avg. Vol 90D

123,452

Relative Vol

5.11

1.81B

1.79B

65,845

Short Interest %

0.00%

1.00

1,666

4,381

8,166

Apr 2, 2014 · 5-for-4

Nov 13, 2026

04:23 PM ESTAstraZeneca gains additional bladder cancer indication for Imfinzi ·

Seeking Alpha

Nov 12, 2026

08:40 AM ESTAstellas, Immuneering Enter Pancreatic Cancer Trial Collaboration ·

RTTNews

Nov 4, 2026

02:57 AM ESTAstellas Pharma (ALPMY) Reports Strong H1 Results, Dividend Sustainability in Focus ·

GuruFocus

02:38 AM ESTAstellas Pharma ADR GAAP EPS of v134.47, revenue of ¥1270.86B; updates FY2027 outlook ·

Seeking Alpha

Nov 3, 2026

06:00 PM ESTHere are the major earnings before the open Wednesday ·

Seeking Alpha

ALPMY Performance

Period	Price	Date	Change	Beta
1W	15.82	2026-11-06	+4.36%	1.445
1M	14.39	2026-10-13	+14.73%	-0.049
3M	14.54	2026-08-13	+13.55%	0.288
6M	15.04	2026-05-13	+9.77%	0.367
1Y	11.97	2025-11-13	+37.93%	0.456
2Y	10.74	2024-11-13	+53.72%	—
5Y	17.42	2021-11-12	-5.21%	0.167

ALPMY Stock Summary

ASTELLAS PHARMA UNSP/ADR (OTC:ALPMY) stock price today is $16.51, and today's volume is 548,974. ALPMY is up 0.182% today. The 30 day average volume is 107,356. ALPMY market cap is $29.88B with 1.81B shares outstanding.